BVS — Bioventus Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Annual balance sheet for Bioventus, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	C2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	86.8	43.9	30.2	37	41.6
Net Total Accounts Receivable
Net Total Receivables	88.4	125	137	123	127
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	212	263	273	268	276
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	21.8	40.2	44.1	50	33.5
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	494	1,226	1,373	811	728
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	123	181	304	175	210
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	352	767	1,047	637	580
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	142	459	325	174	148
Total Liabilities & Shareholders' Equity	494	1,226	1,373	811	728
Total Common Shares Outstanding